Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Funk

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Journal of Pharmacokinetics and Pharmacodynamics|November 26, 2009
Prediction of pharmacokinetic profile of valsartan in human based on in vitro uptake transport dataAgnès Poirier, Anne-Christine Cascais, Christoph Funk, et al.
Journal of Environmental Management|February 20, 2020
Changing climate - Changing livelihood: Smallholder's perceptions and adaption strategiesChristoph Funk, Archana Raghavan Sathyan, Peter Winker, et al.
Drug Discovery Today|December 2, 2016
Minimizing the risk of chemically reactive metabolite formation of new drug candidates: implications for preclinical drug designAndreas Brink, Axel Pähler, Christoph Funk, et al.
Clinical Therapeutics|January 17, 2012
Metabolism, excretion, and pharmacokinetics of [14c]-radiolabeled aleglitazar: a phase I, nonrandomized, open-label, single-center, single-dose study in healthy male volunteersStefan Sturm, Michael Seiberling, Idelette Weick, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|September 28, 2010
Pharmacokinetics and metabolism of the dipeptidyl peptidase IV inhibitor carmegliptin in rats, dogs, and monkeysOlaf Kuhlmann, Axel Paehler, Idelette Weick, et al.
Journal of Orofacial Orthopedics = Fortschritte Der Kieferorthopadie : Organ/Official Journal Deutsche Gesellschaft Fur Kieferorthopadie|April 20, 2011
Pilot study on accuracy and dimensional stability of impression materials using industrial CT technologyStefanie Steinhäuser-Andresen, Andreas Detterbeck, Christoph Funk, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 4, 2014
The need for human breast cancer resistance protein substrate and inhibition evaluation in drug discovery and development: why, when, and how?Agnès Poirier, Renée Portmann, Anne-Christine Cascais, et al.
Biochemical Pharmacology|March 5, 2013
PK/PD assessment in CNS drug discovery: Prediction of CSF concentration in rodents for P-glycoprotein substrates and application to in vivo potency estimationAntonello Caruso, Ruben Alvarez-Sánchez, Alexander Hillebrecht, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 12, 2022
Characterizing the Pharmacokinetics and Biodistribution of Therapeutic Proteins: An Industry White PaperKathryn Ball, Gerard Bruin, Enrique Escandón, et al.
Pediatric Cardiology|July 15, 2024
Fontan Circulation and Aortic Stiffness: Insights into Vascular Dynamics and Haemodynamic InterplayMatthias Walser, Leonie Arnold, Guido Mandilaras, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Journal of Pharmacokinetics and Pharmacodynamics|November 26, 2009
Prediction of pharmacokinetic profile of valsartan in human based on in vitro uptake transport dataAgnès Poirier, Anne-Christine Cascais, Christoph Funk, et al.
Journal of Environmental Management|February 20, 2020
Changing climate - Changing livelihood: Smallholder's perceptions and adaption strategiesChristoph Funk, Archana Raghavan Sathyan, Peter Winker, et al.
Drug Discovery Today|December 2, 2016
Minimizing the risk of chemically reactive metabolite formation of new drug candidates: implications for preclinical drug designAndreas Brink, Axel Pähler, Christoph Funk, et al.
Clinical Therapeutics|January 17, 2012
Metabolism, excretion, and pharmacokinetics of [14c]-radiolabeled aleglitazar: a phase I, nonrandomized, open-label, single-center, single-dose study in healthy male volunteersStefan Sturm, Michael Seiberling, Idelette Weick, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|September 28, 2010
Pharmacokinetics and metabolism of the dipeptidyl peptidase IV inhibitor carmegliptin in rats, dogs, and monkeysOlaf Kuhlmann, Axel Paehler, Idelette Weick, et al.
Journal of Orofacial Orthopedics = Fortschritte Der Kieferorthopadie : Organ/Official Journal Deutsche Gesellschaft Fur Kieferorthopadie|April 20, 2011
Pilot study on accuracy and dimensional stability of impression materials using industrial CT technologyStefanie Steinhäuser-Andresen, Andreas Detterbeck, Christoph Funk, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 4, 2014
The need for human breast cancer resistance protein substrate and inhibition evaluation in drug discovery and development: why, when, and how?Agnès Poirier, Renée Portmann, Anne-Christine Cascais, et al.
Biochemical Pharmacology|March 5, 2013
PK/PD assessment in CNS drug discovery: Prediction of CSF concentration in rodents for P-glycoprotein substrates and application to in vivo potency estimationAntonello Caruso, Ruben Alvarez-Sánchez, Alexander Hillebrecht, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 12, 2022
Characterizing the Pharmacokinetics and Biodistribution of Therapeutic Proteins: An Industry White PaperKathryn Ball, Gerard Bruin, Enrique Escandón, et al.
Pediatric Cardiology|July 15, 2024
Fontan Circulation and Aortic Stiffness: Insights into Vascular Dynamics and Haemodynamic InterplayMatthias Walser, Leonie Arnold, Guido Mandilaras, et al.
Pageof 5